Status epilepticus: pathophysiology and management in adults

Lancet Neurol. 2006 Mar;5(3):246-56. doi: 10.1016/S1474-4422(06)70374-X.

Abstract

As in Clark and Prout's classic work, we identify three phases of generalised convulsive status epilepticus, which we call impending, established, and subtle. We review physiological and subcellular changes that might play a part in the transition from single seizures to status epilepticus and in the development of time-dependent pharmacoresistance. We review the principles underlying the treatment of status epilepticus and suggest that prehospital treatment is beneficial, that therapeutic drugs should be used in rapid sequence according to a defined protocol, and that refractory status epilepticus should be treated with general anaesthesia. We comment on our preference for drugs with a short elimination half-life and discuss some therapeutic choices.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Anesthesia, General / methods
  • Animals
  • Humans
  • Models, Biological
  • Neuroprotective Agents / therapeutic use
  • Seizures / etiology
  • Seizures / therapy
  • Status Epilepticus / diagnosis
  • Status Epilepticus / epidemiology
  • Status Epilepticus / physiopathology*
  • Status Epilepticus / therapy*

Substances

  • Neuroprotective Agents